ES330230A1 - Procedure for the manufacture of quinoline derivatives with veterinary effect. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for the manufacture of quinoline derivatives with veterinary effect. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES330230A1
ES330230A1 ES0330230A ES330230A ES330230A1 ES 330230 A1 ES330230 A1 ES 330230A1 ES 0330230 A ES0330230 A ES 0330230A ES 330230 A ES330230 A ES 330230A ES 330230 A1 ES330230 A1 ES 330230A1
Authority
ES
Spain
Prior art keywords
radical
translation
procedure
manufacture
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0330230A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES330230A1 publication Critical patent/ES330230A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Abstract

Procedure for the manufacture of quinoline derivatives of veterinary effect, of general formula ** (See formula) ** wherein R1 represents an alkyl, aryl or aralkyl radical, any of which may be optionally substituted, and R2 represents an alkyl radical, and wherein the quinoline nucleus carries one or more halogenated substituents, provided that when the quinoline nucleus does not it carries no additional substitute, and when R2 represents the ethyl radical, R1 does not represent the methyl or phenyl radical, and provided that when R1 and R2 represent alkyl radicals of not more than 4 carbon atoms, the quinoline nucleus does not carry as the only additional substitute. an alkoxy radical of not more than 4 carbon atoms in the 6-position, characterized in that it comprises the halogenation of a compound of formula I in which R1 and R2 have the meanings indicated above and the quinoline nucleus has at least one unsubstituted position in the carbocyclic ring. (Machine-translation by Google Translate, not legally binding)
ES0330230A 1965-03-09 1966-08-13 Procedure for the manufacture of quinoline derivatives with veterinary effect. (Machine-translation by Google Translate, not legally binding) Expired ES330230A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9979/65A GB1070223A (en) 1965-03-09 1965-03-09 Quinoline derivatives
GB5123265 1965-12-02

Publications (1)

Publication Number Publication Date
ES330230A1 true ES330230A1 (en) 1967-11-01

Family

ID=26243300

Family Applications (4)

Application Number Title Priority Date Filing Date
ES0323905A Expired ES323905A1 (en) 1965-03-09 1966-03-07 Procedure for the preparation of a veterinary composition. (Machine-translation by Google Translate, not legally binding)
ES0330229A Expired ES330229A1 (en) 1965-03-09 1966-08-13 Procedure for the manufacture of quinoline derivatives of veterinary effect. (Machine-translation by Google Translate, not legally binding)
ES0330228A Expired ES330228A1 (en) 1965-03-09 1966-08-13 Procedure for the manufacture of quinoline derivatives of veterinary effect. (Machine-translation by Google Translate, not legally binding)
ES0330230A Expired ES330230A1 (en) 1965-03-09 1966-08-13 Procedure for the manufacture of quinoline derivatives with veterinary effect. (Machine-translation by Google Translate, not legally binding)

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES0323905A Expired ES323905A1 (en) 1965-03-09 1966-03-07 Procedure for the preparation of a veterinary composition. (Machine-translation by Google Translate, not legally binding)
ES0330229A Expired ES330229A1 (en) 1965-03-09 1966-08-13 Procedure for the manufacture of quinoline derivatives of veterinary effect. (Machine-translation by Google Translate, not legally binding)
ES0330228A Expired ES330228A1 (en) 1965-03-09 1966-08-13 Procedure for the manufacture of quinoline derivatives of veterinary effect. (Machine-translation by Google Translate, not legally binding)

Country Status (12)

Country Link
BE (1) BE677592A (en)
BR (1) BR6677642D0 (en)
CH (2) CH526547A (en)
DE (1) DE1695231B1 (en)
DK (2) DK114480B (en)
ES (4) ES323905A1 (en)
FR (1) FR1487336A (en)
GB (1) GB1070223A (en)
IL (1) IL25347A (en)
MY (1) MY6800068A (en)
NL (1) NL6602994A (en)
SE (1) SE321225B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3397208A (en) * 1965-02-24 1968-08-13 Norwich Pharma Co Method for preparing 4-hydroxy-6, 7-dialkoxy-3-carboalkoxyquinolines and novel 4-chloro-6, 7-dialkoxy-3-carboalkoxyquinolines useful therein
US3472859A (en) * 1966-11-01 1969-10-14 Sterling Drug Inc 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
DE1908548A1 (en) * 1968-02-29 1970-11-05 Warner Lambert Co Quinoline derivatives
US3506667A (en) * 1969-05-01 1970-04-14 Warner Lambert Pharmaceutical Furo quinoline carboxylates
FR2764601B1 (en) * 1997-06-16 1999-09-03 Rhone Merieux PROCESS FOR THE PREPARATION OF TYPE 4- (ALKYL) -3- ALCOXY-ANILINE COMPOUNDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6236247D0 (en) * 1961-02-08 1973-05-24 Norwich Pharma Co PROCESS TO PREPARE HYPOTENSIVE COMPOSITES
GB1007590A (en) * 1962-04-09 1965-10-13 Norwich Pharma Co Lower alkyl esters of 6,7-di(lower)alkoxy-4-hydroxy-3-quinolinecarboxylic acid

Also Published As

Publication number Publication date
FR1487336A (en) 1967-07-07
ES323905A1 (en) 1967-01-16
MY6800068A (en) 1968-12-31
DE1695231B1 (en) 1972-05-04
NL6602994A (en) 1966-09-12
DK114480B (en) 1969-07-07
BR6677642D0 (en) 1973-09-06
IL25347A (en) 1970-01-29
BE677592A (en) 1966-09-09
CH526547A (en) 1972-08-15
GB1070223A (en) 1967-06-01
SE321225B (en) 1970-03-02
DK114410B (en) 1969-06-30
ES330229A1 (en) 1967-09-01
ES330228A1 (en) 1967-09-01
CH539040A (en) 1973-07-15

Similar Documents

Publication Publication Date Title
ES302622A1 (en) Procedure for the preparation of heterociclic derivatives. (Machine-translation by Google Translate, not legally binding)
ES398281A1 (en) O-ethyl-s-n-propyl-o-(substituted phenyl)-phosphorothiolates
ES331997A1 (en) Procedure for the manufacture of tiazol derivatives. (Machine-translation by Google Translate, not legally binding)
ES425900A1 (en) Animal feed containing 7-isopropoxy-isoflavone
ES332806A1 (en) A method of preparing acetals. (Machine-translation by Google Translate, not legally binding)
ES393496A1 (en) Cerivatives of 2-pyrrolidinone
ES336046A1 (en) Procedure for obtaining carbosthritic derivatives (Machine-translation by Google Translate, not legally binding)
ES330230A1 (en) Procedure for the manufacture of quinoline derivatives with veterinary effect. (Machine-translation by Google Translate, not legally binding)
ES350392A1 (en) A method of preparing new benzotriazinones. (Machine-translation by Google Translate, not legally binding)
ES298013A1 (en) Procedure depreparation of new derivatives of the quinolein (Machine-translation by Google Translate, not legally binding)
ES332645A1 (en) Procedure for the preparation of new N-heterocicles. (Machine-translation by Google Translate, not legally binding)
ES335602A1 (en) Procedure for the obtaining of derivatives of the ditiocarbamidic acid. (Machine-translation by Google Translate, not legally binding)
ES397205A1 (en) Ation and their therapeutic application novel derivatives of 1-cinnamyl benzimidazole their process of prepar
ES302872A1 (en) A procedure for the preparation of 3-dialcoylaminoalcoxi-indazoles replaced in position i. (Machine-translation by Google Translate, not legally binding)
ES319725A1 (en) Procedure for the obtaining of amidic derivatives of antimicrobial effect. (Machine-translation by Google Translate, not legally binding)
ES296396A1 (en) Procedure for the obtaining of heterocyclic compounds (Machine-translation by Google Translate, not legally binding)
ES260050A1 (en) Procedure for the preparation of derivatives of 3,4-dihydroquinazoline dehydrogenable to the correspondents of quinazoline (Machine-translation by Google Translate, not legally binding)
ES393339A1 (en) Naphthoquinone derivatives
ES391118A1 (en) Novel glucuronic acid derivatives and process for the preparation thereof
ES275403A1 (en) New procedure for the obtaining of piperacine derivatives (Machine-translation by Google Translate, not legally binding)
ES296162A1 (en) Procedure for the preparation of new hydrazones of 5-nitro-furfurol (Machine-translation by Google Translate, not legally binding)
ES362545A3 (en) Procedure for the preparation of a benzimidazol 2-substituted. (Machine-translation by Google Translate, not legally binding)
ES321477A1 (en) A method for preparing a compound derived from the pirido -2,3-d- pirimidina. (Machine-translation by Google Translate, not legally binding)
ES327049A1 (en) Procedure for the preparation of nicotinic acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES323518A1 (en) A method of preparing a material for the electrophotographic reproduction of images. (Machine-translation by Google Translate, not legally binding)